Resona Asset Management Co.,Ltd. Biomarin Pharmaceutical Inc Transaction History
Resona Asset Management Co.,Ltd.
- $17 Billion
- Q1 2025
A detailed history of Resona Asset Management Co.,Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Resona Asset Management Co.,Ltd. holds 77,264 shares of BMRN stock, worth $4.49 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
77,264
Previous 73,480
5.15%
Holding current value
$4.49 Million
Previous $4.83 Million
13.09%
% of portfolio
0.03%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding BMRN
# of Institutions
669Shares Held
184MCall Options Held
1.24MPut Options Held
957K-
Black Rock Inc. New York, NY22.7MShares$1.32 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.1 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.03 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA15MShares$869 Million0.65% of portfolio
-
Viking Global Investors LP10.8MShares$627 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.8B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...